Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended June 30, 2025. Recent Highlights. Q2 sales g ...

Loan Originations of $1.5 Billion - - Net Income of $4.1 Million - - Diluted Earnings Per Share of $0.29 - MURRAY, Utah, July ...

Full Year Capital Guidance Lowered; Production Guidance Increased Highlights: Generated cash from operating activities of ...

You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy. This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply.